2009 influenza A (H1N1) pandemic

infectious disease

The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.

News

WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season

ECDC comment -

News

Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands

ECDC comment -

News

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland

ECDC comment -

News

New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix

ECDC comment -

News

Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)

ECDC comment -

News

WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season

ECDC comment -

News

Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands

ECDC comment -

News

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland

ECDC comment -

News

New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix

ECDC comment -

News

Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)

ECDC comment -

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

23 Oct 2015
Geneva, Switzerland

Event

Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived

23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden

Peer-Reviewed Publication

Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017

Apr 2018

Peer-Reviewed Publication

Dominant influenza A(H3N2) and B/yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively

Mar 2018

Peer-Reviewed Publication

Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

Mar 2018

Peer-Reviewed Publication

2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.

Jan 2018

Peer-Reviewed Publication

Enablers and Barriers to Community Engagement in Public Health Emergency Preparedness: A Literature Review

Jan 2018
19 February 2015 - Assessment of human influenza pandemic scenarios in Europe
06 June 2013 - Critical care surveillance: insights into the impact of the 2010/11 influenza season relative to the 2009/10 pandemic season in England
11 April 2013 - Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden
17 January 2013 - Within-patient emergence of the influenza A(H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway
08 November 2012 - Hospitalisation associated with the 2009 H1N1 pandemic and seasonal influenza in Hong Kong, 2005 to 2010